Results of Operations and Financial Condition On July 28, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the release is furnished herewith as Exhibit 99.

Results of Operations and Financial Condition On April 23, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the release is furnished herewith as Exhibit 99.

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”). JPMorgan Chase Bank, N.A., acted as the Administrative Agent, Joint Lead Arranger and Joint Bookrunner. Bank of America, N.A., acted as Joint Lead Arranger, Joint Bookrunner and Syndication Agent. PNC Bank, N.A. and U.S. Bank, N.A. were Co-Documentation Agents. Terms of the Credit Facilities consist of a five-year…

CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT The information set forth above under

Results of Operations and Financial Condition On February 25, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended December 31, 2025. A copy of the release is furnished herewith as Exhibit 99.

Results of Operations and Financial Condition On October 28, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the release is furnished herewith as Exhibit 99.

Results of Operations and Financial Condition On July 29, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the release is furnished herewith as Exhibit 99.

CEO — Nicholas M. Westfall: The CEO of a subsidiary (Vitas) is resigning to pursue other interests, which constitutes a genuine executive departure, though the neutral direction reflects the stated reason and his continued role at the parent company.

Results of Operations and Financial Condition On April 23, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2025. A copy of the release is furnished herewith as Exhibit 99.

Results of Operations and Financial Condition On February 26, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended December 31, 2024. A copy of the release is furnished herewith as Exhibit 99.

Results of Operations and Financial Condition On October 29, 2024, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2024. A copy of the release is furnished herewith as Exhibit 99.

Results of Operations and Financial Condition On July 24, 2024, Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2024. A copy of the release is furnished herewith as Exhibit 99.

Results of Operations and Financial Condition On April 24, 2024, Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2024. A copy of the release is furnished herewith as Exhibit 99.

Completion of Acquisition or Disposition of Assets VITAS Acquisition On April 17, 2024, Chemed issued a press release announcing that VITAS Healthcare Corporation (“VITAS”), a wholly-owned indirect subsidiary of Chemed, completed its acquisition of substantially all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc., d/b/a Covenant Care, a Florida not for profit corporation (“Covenant”), for $85 million. Covenant operated hospice services in t…